Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Time-varying association of first-line bevacizumab with progression-free survival in advanced ovarian cancer: A multicenter matched cohort study.

Randomized trials have demonstrated that first-line bevacizumab extends progression-free survival (PFS) in advanced ovarian cancer. However, its long-term effectiveness in routine clinical practice remains unclear. This study investigated the time-varying association between first-line bevacizumab and PFS in patients n...

K. Katić, Dora Čerina Pavlinović, I. Canjko et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.